---
title: "Pegademase - Adenosine Deaminase Deficiency"
sidebar: mydoc_sidebar
permalink: db00061-mesh-c531816-1.html
toc: false 
---


Path ID: `DB00061_MESH_C531816_1`
{% include image.html url="images/db00061-mesh-c531816-1.png" file="db00061-mesh-c531816-1.png" alt="db00061-mesh-c531816-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C051409 | Pegademase | Drug |
| CHEBI:17256 | 2'-deoxyadenosine | ChemicalSubstance |
| CL:0000084 | T cell | Cell |
| GO:0002456 | T cell mediated immunity | BiologicalProcess |
| MESH:C531816 | Adenosine deaminase deficiency | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Pegademase | DECREASES ABUNDANCE OF | 2'-Deoxyadenosine |
| 2'-Deoxyadenosine | DISRUPTS | T Cell |
| T Cell | POSITIVELY CORRELATED WITH | T Cell Mediated Immunity |
| T Cell Mediated Immunity | NEGATIVELY CORRELATED WITH | Adenosine Deaminase Deficiency |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00061](https://go.drugbank.com/drugs/DB00061)
  - [https://en.wikipedia.org/wiki/Adenosine_deaminase_deficiency](https://en.wikipedia.org/wiki/Adenosine_deaminase_deficiency)
